<DOC>
	<DOCNO>NCT01487499</DOCNO>
	<brief_summary>This project propose use bronchoscopic intratumoral chemotherapy small cell lung cancer two fashion : 1. implement prospective clinical trial test feasibility efficacy intralesional chemotherapy consolidative therapy immediately follow standard systemic chemotherapy radiation therapy patient limited stage SCLC compare tumor growth survival rate treatment group compare outcomes historical control 2. implement prospective clinical trial test feasibility efficacy measure tumor growth survival rate intralesional chemotherapy patient recurrent SCLC standard treatment .</brief_summary>
	<brief_title>Bronchoscopic Intratumoral Chemotherapy Small Cell Lung Cancer ( SCLC )</brief_title>
	<detailed_description>Subjects receive standard care treatment SCLC add treatment Cisplatin injection via endobronchial ultrasound aid bronchoscopy total four time . Outcome measurement tumor growth survival compare subject receive standard care treatment .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Competent adult English speaking subject With limited stage SCLC complete standard care treatment responder evidence disseminate disease CNS metastasis , With recurrent disseminate SCLC standard care treatment symptom related central tumor obstruction , With recurrent limit stage SCLC mediastinal/hilar recurrence previously treat intratumoral cisplatin Subjects meet inclusion criterion Subjects , opinion investigator , risk undergoing bronchoscopy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>